Imagine a future where parents can choose their baby's traits. In-vitro gametogenesis (IVG) is making this closer to reality ...

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

Large language models unleashed the power of AI. Now it’s time for more efficient AIs to take over. After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and ...

Technological Innovation: The rapid pace of technological innovation in single cell isolation, sequencing, and analysis techniques is a primary driver of market growth. These advancements have ...

Adia Inc. (OTC Pink: ADIA), through its medical division Adia Med, is strategically positioning itself to capture a ...

Mentioning advances in AI and telemedicine, Kennedy highlighted the opportunity to make breakthroughs in healthcare.

The Global Stem Cell Therapy For Diabetes Related Conditions market industry is primarily driven by the continuous advancements in technology.

Research on lab-produced eggs and sperm, known as in-vitro gametogenesis (IVGs), is advancing quickly, with potential for future fertility treatments.

Scientists have successfully created a mouse from two biological fathers which has survived until adulthood, a new study has revealed. In a scientific first, the mouse was created by Chinese ...

Using cutting-edge stem cell technology, a team of scientists from the Chinese Academy of Sciences (CAS) recently created a mouse with two biological fathers.

Scientists in China have engineered embryonic stem cells to produce lab mice with two male parents. Though these mice reached adulthood with developmental issues, the method offers insights into ...

A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse—a mouse ...